ID

32627

Descripción

Comparing the Metabolic Control of Once to Twice-daily Insulin Detemir Injections; ODM derived from: https://clinicaltrials.gov/show/NCT00542399

Link

https://clinicaltrials.gov/show/NCT00542399

Palabras clave

Versiones (1)
  1. 8/11/18 8/11/18 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

8 de noviembre de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Type 1 Diabetes Mellitus NCT00542399

Inglés

Eligibility Type 1 Diabetes Mellitus NCT00542399

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. informed consent obtained before any trial related activity
Descripción

Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
2. children with type 1 diabetes who have been treated with insulin for at least 12 months prior to the study.
Descripción

Children | Diabetes Mellitus, Insulin-Dependent | Insulin regime

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0008059
UMLS CUI [2]
C0011854
UMLS CUI [3]
C0557978
3. age > 6 years and < 18 years
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
4. hba1c > 7.7%
Descripción

Hemoglobin A1c measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0474680
5. ability and willingness to accept the study conditions and to inject insulin detemir
Descripción

Protocol Compliance | Insulin detemir Injection

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0525058
UMLS CUI [2,1]
C0537270
UMLS CUI [2,2]
C1828121
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. impaired renal function or current renal dialysis.
Descripción

Renal Insufficiency | Dialysis procedure

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1565489
UMLS CUI [2]
C0011946
2. acute or chronic metabolic acidosis, including diabetic ketoacidosis.
Descripción

Metabolic acidosis | Chronic metabolic acidosis | Diabetic Ketoacidosis

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0220981
UMLS CUI [2]
C0740749
UMLS CUI [3]
C0011880
3. known hypoglycemia unawareness.
Descripción

Hypoglycemia unawareness.

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0342317
4. known or suspected allergy to trial products.
Descripción

Hypersensitivity Investigational New Drugs | Hypersensitivity Suspected Investigational New Drugs

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013230
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0750491
UMLS CUI [2,3]
C0013230
5. clinical evidence of active liver disease or impaired hepatic function
Descripción

Liver diseases | Liver Dysfunction

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023895
UMLS CUI [2]
C0086565
6. participation in another study (with study drug) within the last 3 months prior to this trial.
Descripción

Study Subject Participation Status | Investigational New Drugs

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0013230
7. significant concomitant disease likely to interfere with glucose metabolism
Descripción

Comorbidity Interferes with Glucose metabolism

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C0596620
8. proven eating disorders
Descripción

Eating Disorders

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0013473
9. malignancy within the last 5 years
Descripción

Malignant Neoplasms

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006826
10. history of repeated severe hypoglycemia within the last year.
Descripción

Hypoglycemia Severe Repeated

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020615
UMLS CUI [1,2]
C0205082
UMLS CUI [1,3]
C0205341
11. known diabetes retinopathy
Descripción

Diabetic Retinopathy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0011884
Volver a la parte superior de la página

Similar models

Eligibility Type 1 Diabetes Mellitus NCT00542399

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent
Item
1. informed consent obtained before any trial related activity
boolean
C0021430 (UMLS CUI [1])
Children | Diabetes Mellitus, Insulin-Dependent | Insulin regime
Item
2. children with type 1 diabetes who have been treated with insulin for at least 12 months prior to the study.
boolean
C0008059 (UMLS CUI [1])
C0011854 (UMLS CUI [2])
C0557978 (UMLS CUI [3])
Age
Item
3. age > 6 years and < 18 years
boolean
C0001779 (UMLS CUI [1])
Hemoglobin A1c measurement
Item
4. hba1c > 7.7%
boolean
C0474680 (UMLS CUI [1])
Protocol Compliance | Insulin detemir Injection
Item
5. ability and willingness to accept the study conditions and to inject insulin detemir
boolean
C0525058 (UMLS CUI [1])
C0537270 (UMLS CUI [2,1])
C1828121 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
Renal Insufficiency | Dialysis procedure
Item
1. impaired renal function or current renal dialysis.
boolean
C1565489 (UMLS CUI [1])
C0011946 (UMLS CUI [2])
Metabolic acidosis | Chronic metabolic acidosis | Diabetic Ketoacidosis
Item
2. acute or chronic metabolic acidosis, including diabetic ketoacidosis.
boolean
C0220981 (UMLS CUI [1])
C0740749 (UMLS CUI [2])
C0011880 (UMLS CUI [3])
Hypoglycemia unawareness.
Item
3. known hypoglycemia unawareness.
boolean
C0342317 (UMLS CUI [1])
Hypersensitivity Investigational New Drugs | Hypersensitivity Suspected Investigational New Drugs
Item
4. known or suspected allergy to trial products.
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0750491 (UMLS CUI [2,2])
C0013230 (UMLS CUI [2,3])
Liver diseases | Liver Dysfunction
Item
5. clinical evidence of active liver disease or impaired hepatic function
boolean
C0023895 (UMLS CUI [1])
C0086565 (UMLS CUI [2])
Study Subject Participation Status | Investigational New Drugs
Item
6. participation in another study (with study drug) within the last 3 months prior to this trial.
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
Comorbidity Interferes with Glucose metabolism
Item
7. significant concomitant disease likely to interfere with glucose metabolism
boolean
C0009488 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0596620 (UMLS CUI [1,3])
Eating Disorders
Item
8. proven eating disorders
boolean
C0013473 (UMLS CUI [1])
Malignant Neoplasms
Item
9. malignancy within the last 5 years
boolean
C0006826 (UMLS CUI [1])
Hypoglycemia Severe Repeated
Item
10. history of repeated severe hypoglycemia within the last year.
boolean
C0020615 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0205341 (UMLS CUI [1,3])
Diabetic Retinopathy
Item
11. known diabetes retinopathy
boolean
C0011884 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial